4588 — Oncolys Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Oncolys Biopharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,068	3,455	1,711	1,533	2,411
Net Total Accounts Receivable
Net Total Receivables	168	377	318	102	148
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,546	4,198	2,609	1,956	3,098
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21.3	0	0	0	0
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,796	4,292	2,651	2,041	3,199
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	415	430	322	379	252
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	793	698	492	567	447
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	2,003	3,594	2,159	1,474	2,752
Total Liabilities & Shareholders' Equity	2,796	4,292	2,651	2,041	3,199
Total Common Shares Outstanding